WallStreetZenWallStreetZen

NASDAQ: THRX
Theseus Pharmaceuticals Inc Stock

$13.69+0.30 (+2.24%)
Updated Feb 3, 2023
THRX Price
$13.69
Fair Value Price
N/A
Market Cap
$529.99M
52 Week Low
$4.01
52 Week High
$15.21
P/E
0.92x
P/B
2.42x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$45.55M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.05
Operating Cash Flow
-$33M
Beta
1.53
Next Earnings
Mar 9, 2023
Ex-Dividend
N/A
Next Dividend
N/A

THRX Overview

Theseus Pharmaceuticals Incorporated is a biopharmaceutical company that develops cancer treatments. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company's development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. Theseus Pharmaceuticals was incorporated in 2017 and is headquartered in Cambridge, MA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how THRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

THRX is good value based on its earnings relative to its share price (0.92x), compared to the US market average (15.09x)
P/E vs Market Valuation
THRX is good value based on its earnings relative to its share price (0.92x), compared to the US Biotechnology industry average (10.7x)
P/E vs Industry Valuation
THRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more THRX due diligence checks available for Premium users.

Be the first to know about important THRX news, forecast changes, insider trades & much more!

THRX News

Valuation

THRX fair value

Fair Value of THRX stock based on Discounted Cash Flow (DCF)
Price
$13.69
Fair Value
$11.03
Overvalued by
24.06%

THRX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
0.92x
Industry
10.7x
Market
15.09x
THRX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
THRX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

THRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.42x
Industry
5.11x
THRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

THRX's financial health

Profit margin

Revenue
$0.0
Net Income
-$14.7M
Profit Margin
0%
THRX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$230.3M
Liabilities
$11.7M
Debt to equity
0.05
THRX's short-term assets ($215.00M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
THRX's short-term assets ($215.00M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
THRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.2M
Investing
-$12.3M
Financing
$0.0
THRX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

THRX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
THRX$529.99M+2.24%0.92x2.42x
ERAS$532.27M+4.82%-5.12x1.46x
SIGA$533.81M-5.56%5.04x3.08x
NUVB$524.14M-2.44%-4.80x0.78x
CGEM$538.74M-1.18%5.05x0.92x

Theseus Pharmaceuticals Stock FAQ

What is Theseus Pharmaceuticals's quote symbol?

NASDAQ: THRX) Theseus Pharmaceuticals trades on the NASDAQ under the ticker symbol THRX. Theseus Pharmaceuticals stock quotes can also be displayed as NASDAQ: THRX.

If you're new to stock investing, here's how to buy Theseus Pharmaceuticals stock.

What is the 52 week high and low for Theseus Pharmaceuticals (NASDAQ: THRX)?

(NASDAQ: THRX) Theseus Pharmaceuticals's 52-week high was $15.21, and its 52-week low was $4.01. It is currently -9.99% from its 52-week high and 241.4% from its 52-week low.

How much is Theseus Pharmaceuticals stock worth today?

(NASDAQ: THRX) Theseus Pharmaceuticals currently has 38,713,430 outstanding shares. With Theseus Pharmaceuticals stock trading at $13.69 per share, the total value of Theseus Pharmaceuticals stock (market capitalization) is $529.99M.

Theseus Pharmaceuticals stock was originally listed at a price of $18.58 in Oct 7, 2021. If you had invested in Theseus Pharmaceuticals stock at $18.58, your return over the last 1 years would have been -26.32%, for an annualized return of -26.32% (not including any dividends or dividend reinvestments).

How much is Theseus Pharmaceuticals's stock price per share?

(NASDAQ: THRX) Theseus Pharmaceuticals stock price per share is $13.69 today (as of Feb 3, 2023).

What is Theseus Pharmaceuticals's Market Cap?

(NASDAQ: THRX) Theseus Pharmaceuticals's market cap is $529.99M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Theseus Pharmaceuticals's market cap is calculated by multiplying THRX's current stock price of $13.69 by THRX's total outstanding shares of 38,713,430.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.